Tiziana Monteverde

AstraZeneca (United Kingdom) — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index991citations63works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(24), Cancer-related gene regulation(16), RNA Research and Splicing(13), Pancreatic and Hepatic Oncology Research(7), Lung Cancer Treatments and Mutations(7)

Publications63 total

High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS
SLAS DISCOVERY·2024· 3 citedOpen Access
Abstract C038: High throughput application of the NanoBiT Biochemical Assay for the discovery of selective p110α isoform binders that block its interaction with KRAS
Molecular Cancer Therapeutics·2023
Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma
Frontiers in Toxicology·2023· 9 citedOpen Access
Optimizing the Cell Painting assay for image-based profiling
Nature Protocols·2023· 144 cited
Data from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Supplementary Material from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2023Open Access
Figures S1-S6 & Tables S1 & S2 from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Supplementary Methods from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Supplementary Table 3 from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Supplementary Methods from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Table S4 from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2023Open Access
Data from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2023Open Access
Data from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2023Open Access
Data from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Table S4 from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2023Open Access
Supplementary Material from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2023Open Access
Supplementary Table 3 from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Figures S1-S6 & Tables S1 & S2 from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
2023Open Access
Supplementary Figure 4 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Table 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Michela Garofalo(20), Lei Shi(19), Peter Magee(19), Matteo Fassan(19), Sudhakar Sahoo(19), Hui Sun Leong(19), Ann Hedley(18), Daniel J. Murphy(18), Manuela La Montagna(18), Alexander R. Baker(18), Katarína Gyurászová(17), Dave Lee(17), Robert M. Sellers(17), Björn Kruspig(16), Nathiya Muthalagu(14), Colin Nixon(14), Owen J. Sansom(14), Sarah Neidler(9), Jennifer Port(9), Meera Raja(8)